CXCL12, which led to PI3K and ERK1/2 activation in tumour cells, and CCL2, which was released by stromal cells and tumour cells to recruit myeloid cells, exhibited significantly increased expression in the exhausted groups than in the active groups (Fig. 2i) [12]. This evidence concerns the gene CCL2 and neoplasm.